Literature DB >> 11092450

The role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy.

D M Kullmann1, F Asztely, M C Walker.   

Abstract

Synaptic plasticity is the foremost candidate mechanism to explain the rapid acquisition of memories. In the mammalian brain, the NMDA subclass of glutamate receptors plays a central role in the induction of several forms of use-dependent plasticity. The finding that modifications in synaptic strength are largely expressed by receptors of the AMPA subclass has focused attention on molecular mechanisms that affect their function and targeting. Receptor plasticity has also been reported in pathological situations, notably in animal and human forms of epilepsy. Which of these changes are causally implicated in the generation of seizures, and which may be compensatory or neuroprotective adaptations, has not been fully resolved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092450     DOI: 10.1007/pl00000640

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  19 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

Review 3.  Target-cell-dependent plasticity within the mossy fibre-CA3 circuit reveals compartmentalized regulation of presynaptic function at divergent release sites.

Authors:  Kenneth A Pelkey; Chris J McBain
Journal:  J Physiol       Date:  2007-12-13       Impact factor: 5.182

Review 4.  The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence.

Authors:  Michael J Glass
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

5.  A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.

Authors:  Xiao-lei Zhang; John A Sullivan; Joseph R Moskal; Patric K Stanton
Journal:  Neuropharmacology       Date:  2008-08-29       Impact factor: 5.250

6.  Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons.

Authors:  Davide Ragozzino; Silvia Di Angelantonio; Flavia Trettel; Cristina Bertollini; Laura Maggi; Cornelius Gross; Israel F Charo; Cristina Limatola; Fabrizio Eusebi
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

7.  [Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision].

Authors:  E M Pogatzki-Zahn; J S Niemeier; L S Sorkin; T J Brennan
Journal:  Schmerz       Date:  2006-06       Impact factor: 1.107

8.  Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  M J Glass; L Vanyo; L Quimson; V M Pickel
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

9.  Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability.

Authors:  Michelle M Adams; Lei Shi; M Constance Linville; M Elizabeth Forbes; Ashley B Long; Colleen Bennett; Isabel G Newton; Christy S Carter; William E Sonntag; David R Riddle; Judy K Brunso-Bechtold
Journal:  Exp Neurol       Date:  2008-02-08       Impact factor: 5.330

Review 10.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.